Exendin-4 Inhibits Glioma Cell Migration, Invasion and Epithelial-to-Mesenchymal Transition Through GLP-1R/Sirt3 Pathway
Tirzepatide Semaglutide (Ozempic/Wegovy) activates GLP-1 receptors, which: Slows stomach emptying Reduces appetite Improves insulin sensitivity Typically results in 15-20% weight loss over a year Tirzepatide (Mounjaro/Zepbound) activates both GLP-1 and GIP receptors, which: Provides all semaglutide benefits May have stronger effects on glucose metabolism Often results in 20-25% weight loss over a year Sometimes has fewer gastrointestinal side effects Your optimal choice depends on your specific PCOS presentation
For road trips, use an insulated bag with ice packs, and avoid leaving your medication in the car for long periodsespecially in hot weather or direct sunlight
The main symptoms are widespread pain, severe fatigue, sleep problems, and cognitive difficulties (often called fibro fog)
Diabetologia 59 , 14121421 (2016)